Biological Agents Involved in Malignant Mesothelioma: Relevance as Biomarkers or Therapeutic Targets

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|10|1|19-26

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.10, Iss.1, 2010-02, pp. : 19-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Targets in Malignant Pleural Mesothelioma Treatment

By  

Current Drug Targets, Vol. 10, Iss. 12, 2009-12 ,pp. : 1235-1244

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Targets and Targeted Therapies for Malignant Mesothelioma

By  

Current Medicinal Chemistry, Vol. 15, Iss. 9, 2008-04 ,pp. : 855-867

Bentham Science Publishers

Access to resources Recommend Favorite

Malignant Mesothelioma: Biology, Diagnosis and Therapeutic Approaches

By  

Current Molecular Pharmacology, Vol. 2, Iss. 2, 2009-06 ,pp. : 190-206

Bentham Science Publishers

Access to resources Recommend Favorite

Gangliosides: therapeutic agents or therapeutic targets?

By Saragovi H Uri   Gagnon Martin  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 8, 2002-08 ,pp. : 1215-1223

Informa Healthcare

Access to resources Recommend Favorite

Androgen Metabolic Pathway Involved in Current and Emerging Treatment for Men with Castration Resistant Prostate Cancer: Intraprostatic Androgens as Therapeutic Targets and Endocrinological Biomarkers

By  

Current Drug Targets, Vol. 15, Iss. 13, 2014-12 ,pp. : 1215-1224

Bentham Science Publishers

Access to resources Recommend Favorite